Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines for orphan diseases.
| Website: | www.amicusrx.com |
| Email: | ir@amicustherapeutics.com |
| Main Phone: | +1 609 662-2000 |
| Address: | 1 Cedar Brook Drive |
| State: | NJ |
| City / Town: | Cranbury |
| Country: | USA |
| Postal Code: | 08512 |
| Exchange: | NSD |
| Employees: | 185 |
| NAICS: | Pharmaceutical P |
| Last Price 12.50 | Change $ -0.01 | Change % -0.08 | Tick N/A |
| Bid 12.49 | Bid Size 500.00 | Ask 12.51 | Ask Size 300.00 |
| Open 12.48 | High 12.53 | Low 12.41 | Prev Close 12.51 |
| Last Trade | Volume 66,091 | 52 Wk Hi 14.05 | 52 Wk Low 4.41 |
| Market Cap 2.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 164,566,069.00 | EPS (TTM) -1.48 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 12 | 50 |
| Number of Buys | 9 | 33 |
| Number of Sells | 3 | 17 |
| Net Activity | 86793 | 887299 |
| Last 10 Buys | Shares |
|---|---|
| Ellen S. Rosenberg | 1,000 |
| Margaret G. McGlynn | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Hung Do | 1,000 |
| Jay Barth | 1,000 |
| Jay Barth | 1,000 |
| Daphne Quimi | 1,000 |
| Kenneth Peist | 1,000 |
| Bradley L. Campbell | 1,000 |
| William D. Baird | 1,000 |
| Hung Do | 1,000 |
| Daphne Quimi | 1,000 |
| John F. Crowley | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 19 | 19 | 19 | 19 |
| Low Target Price Estimate | 9 | 9 | 9 | 9 |
| Mean Target Price Estimate | 13.33 | 14 | 14 | 13.33 |
| Standard Deviation | 3.72 | 3.83 | 3.83 | 3.72 |
| Date of Most Recent Estimate | 08/16/16 | 08/09/16 | 08/03/16 | 08/23/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-26 |
| 8-K | Report of unscheduled material events or corporate changes. | 16 | 2016-08-23 |
| CT ORDER | 1 | 2016-08-19 | |
| 8-K | Report of unscheduled material events or corporate changes. | 47 | 2016-08-10 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 45 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 28 | 2016-08-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-29 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2016-07-29 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.33 | 1.29 | 1.29 | 1.29 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
